Advertising and generic market entry

Journal of Health Economics

Volumn 26, Issue 2, 2007, Pages 286-305

  Königbauer, Ingrid ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Advertising; Generic entry; Pharmaceuticals; Social welfare

Indexed keywords

GENERIC DRUG;

ADVERTISING; COMPETITION (ECONOMICS); DRUG; MARKET CONDITIONS; MARKET SYSTEM; WELFARE ECONOMICS;

ADVERTIZING; ARTICLE; COMPETITION; DRUG INDUSTRY; DRUG MARKETING; ECONOMIC ASPECT; MARKET; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; PHYSICIAN ATTITUDE; PRESCRIPTION; SOCIAL WELFARE;

ADVERTISING; DRUGS, GENERIC; ECONOMIC COMPETITION; GERMANY; HUMANS; MODELS, STATISTICAL; SOCIAL WELFARE;

EID: 33847140199     PISSN: 01676296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhealeco.2006.08.008     Document Type: Article

References (26)

1. Avon J., Chen M., and Hartley R. Scientific vs. commercial sources of influence on the prescribing behaviors of physicians. American Journal of Medicine 73 1 (1982) 4-8
2. Brekke K.R., and Kuhn M. Direct-to-consumer advertising in pharmaceutical markets. Journal of Health Economics 25 (2006) 102-130
3. Cabrales, A., 2003. Pharmaceutical generics, vertical product differentiation, and public policy. Working Paper UPF 662.
4. Caves R.E., Whinston M.D., and Hurwitz M.A. Patent expiration, entry, and competition in the U.S. pharmaceutical industry. Brookings Papers on Economic Activity (1992) 1-48
5. Chren M.-M., and Landefeld C.S. Physicians' behavior and their interactions with drug companies. Journal of the American Medical Association 271(9) (1994) 684-689
6. Dixit A., and Norman V. Advertising and welfare. Bell Journal of Economics 9 (1978) 1-17
7. Frank R.G., and Salkever D.S. Pricing, patent loss and the market for pharmaceuticals. Southern Economic Journal 59 (1992) 165-179
8. Fridman D., Jaffe A., and Steinhardt S. Physicians' attitudes toward and knowledge about generic drug substitution. New York State Journal of Medicine 87 (1987) 539-542
9. Fudenberg D., and Tirole J. The fat-cat effect, the puppy-dog ploy, and the lean and hungry look. American Economic Review Papers and Proceedings 74 (1984) 361-366
10. Gabszewicz J.J., and Thisse J. Price competition, quality and income disparities. Journal of Economic Theory 20 3 (1979) 340-359
11. Hellerstein J.K. The importance of the physician in the generic versus trade-name prescription decision. RAND Journal of Economics 29 1 (1998) 108-136
12. Hurwitz M.A., and Caves R.E. Persuasion or information? Promotion and the shares of brand name and generic pharmaceuticals. Journal of Law and Economics 31 (1988) 299-320
13. Ishigati H. Informative advertising and entry deterrence: a Bertrand model. Economic Letters 67 (2000) 337-343
14. Jacobzone, S., 2000. Pharmaceutical policies in OECD countries: reconciling social and industrial goals, Labour Market and Social Policy-Occasional Papers No. 40, Organisation for Economic Cooperation and Development, Paris.
15. Königbauer I. Advertising, generic competition and price regulation in pharmaceutical markets. CESifo Economic Studies 523 3 (2006) 565-586
16. Konrad, K.A., 2002. Competition for prescription drugs, Discussion Paper.
17. Leffler K.B. Persuasion or information? The economics of prescription drug advertising. Journal of Law and Economics 24 S (1980) 45-74
18. Lundin D. Moral hazard in physician prescription behavior. Journal of Health Economics 19 (2000) 639-662
19. Rizzo J.A. Advertising and competition in the ethical pharmaceutical industry: the case of antihypertensive drugs. Journal of Law and Economics 42 (1999) 89-116
20. Scherer F.M. The parmaceutical industry. In: Culyer A.J., and Newhouse J.P. (Eds). Handbook of Health Economics I (2000), Elsevier, Amsterdam
21. Schmalensee R. Advertising and entry deterrence: an exploratory model. Journal of Political Economy 91 4 (1983) 636-653
22. Scott Morton F.M. Barriers to entry, brand advertising, and generic entry in the U.S. pharmaceutical industry. International Journal of Industrial Organization 18 7 (2000) 1085-1104
23. Shaked A., and Sutton J. Relaxing price competition through product differentiation. Review of Economic Studies 99 (1982) 3-13
24. Taggart J. The world pharmaceutical industry. Thomson Learning, Routledge (1993)
25. Telser L.G., Best W., Egan J.W., and Higinbotham H.N. The theory of supply with applications to the ethical pharmaceutical industry. Journal of Law and Economics 18 2 (1975) 449-478
26. Vernon J.M. Concentration, promotion, and market share stability in the pharmaceutical industry. Journal of Industrial Economics 19 3 (1971) 246-266